SARS-CoV-2 Delta variant induces enhanced pathology and inflammatory responses in K18-hACE2 mice
K. S. Lee, T. Y. Wong, B. P. Russ, A. M. Horspool, O. Miller, N. Rader, J. P. Givi, M. T. Winters, Z. Y. Wong, H. A. Cyphert, J. Denvir, P. G. Stoilov, M. Barbier, N. Roan, M. S. Amin, I. Martinez, J. R. Bevere, F. H. Damron
Abstract
The COVID-19 pandemic has been fueled by novel variants of concern (VOC) that have increased transmissibility, receptor binding affinity, and other properties that enhance disease. The goal of this study is to characterize unique pathogenesis of the Delta VOC strain in the K18-hACE2-mouse challenge model. Challenge studies suggested that the lethal dose of Delta was higher than Alpha or Beta strains. To characterize the differences in the Delta strains pathogenesis, a time-course experiment was performed to evaluate the overall host response to Alpha or Delta variant challenge. qRT-PCR analysis of Alpha- or Delta- challenged mice revealed no significant difference between viral RNA burden in the lung, nasal wash or brain. However, histopathological analysis revealed high lung tissue inflammation and cell infiltration following Delta- but not Alpha-challenge at day 6. Additionally, pro-inflammatory cytokines were highest at day 6 in Delta-challenged mice suggesting enhanced pneumonia. Total RNA-sequencing analysis of lungs comparing infected to uninfected mice revealed that Alpha-challenged mice have more total genes differentially activated, conversely, Delta-challenged mice have a higher magnitude of differential gene expression. Delta-challenged mice have increased interferon-dependent gene expression and IFN-{gamma} production compared to Alpha. Analysis of TCR clonotypes suggested that Delta challenged mice have increased T-cell infiltration compared to Alpha challenged. Our data suggest that Delta has evolved to engage interferon responses in a manner that may enhance pathogenesis. The in vivo and in silico observations of this study underscore the need to conduct experiments with VOC strains to best model COVID-19 when evaluating therapeutics and vaccines. ImportanceThe Delta variant of SARS-CoV-2 is known to be more transmissible and cause severe disease in human hosts due to mutations in its genome that are divergent from previous variants of concern (VOC). Our study evaluates the pathogenesis of Delta in the K18-hACE2 mouse model compared to the Alpha VOC. We observed that relative to Alpha, Delta challenge results in enhanced inflammation and tissue damage with stronger antiviral responses. These observations provide insight into Deltas unique pathogenesis.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Differential outcomes of infection by wild-type SARS-CoV-2 and the B.1.617.2 and B.1.1.529 variants of concern in K18-hACE2 transgenic mice
Y. Yicheng He, J. E. Henley, … L. Comai·bioRxiv·Sep 8, 2023
- Differential pathogenesis of SARS-CoV-2 variants of concern in human ACE2-expressing mice
J. P. Natekar, H. Pathak, … M. Kumar·bioRxiv·Apr 4, 2022
- COMPARATIVE CHARACTERISTICS OF THE ACCUMULATION OF DIFFERENT VARIANTS OF THE SARS-COV-2 VIRUS (WUHAN, DELTA, OMICRON) IN THE ORGANS OF MODEL ANIMALS
А. С. Чернов, V.A. Kazakov, … Alexey A. Belogurov·bioRxiv·Nov 12, 2024
- B.1.1.7 and B.1.351 variants are highly virulent in K18-ACE2 transgenic mice and show different pathogenic patterns from early SARS-CoV-2 strains
P. Radvak, H. J. Kwon, … H. Xie·bioRxiv·Jun 5, 2021
- A Murine Model of Post-acute Neurological Sequelae Following SARS-CoV-2 Variant Infection
Ankita Singh, Awadalkareem Adam, … Tian Wang·Frontiers in ImmunologyPeer-reviewed·May 3, 2024
- The Delta variant of SARS-CoV-2 maintains high sensitivity to interferons in human lung cells
R. Nchioua, A. Schundner, … K. Sparrer·bioRxiv·Nov 16, 2021